Gsk (GSK) Tax Rate (2009 - 2026)
Gsk (GSK) posted quarterly Tax Rate of 56.21% for Q2 2026, up 6899.0% year-over-year from 0.8% in Q2 2025, and up 495.16% quarter-over-quarter from 14.23% in Q1 2026.
Gsk (GSK) Tax Rate (2009 - 2026) Analysis & Trends
Gsk's Tax Rate history runs 18 years deep, the most recent figure standing at 56.21% for Q2 2026.
- In Q2 2026, Tax Rate rose 6899.0% year-over-year to 56.21%; the TTM figure through Jun 2026 stood at 17.05% (down 113.0% YoY), while the FY2025 annual figure was 15.02%, down 10.0% from the prior year.
- Tax Rate for Q2 2026 stood at 56.21%, up from 14.23% in the prior quarter.
- The five-year high for Tax Rate was 56.21% in Q2 2026, with the low at 27.83% in Q4 2025.
- The 5-year median for Tax Rate is 14.29% (2023), against an average of 8.17%.
- The sharpest annual moves came in 2022 and 2026: Tax Rate slumped 4038 bps in 2022, then soared 6899 bps in 2026.
- Gsk's Tax Rate stood at 23.65% in 2022, then increased by 18 bps to 19.41% in 2023, then grew by 5 bps to 18.46% in 2024, then sank by 51 bps to 27.83% in 2025, then jumped by 302 bps to 56.21% in 2026.
- Business Quant data shows GSK's Tax Rate at 56.21% in Q2 2026, 14.23% in Q1 2026, and 27.83% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 23.71% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 10.40% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 14.20% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -2.36% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 62.33% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 56.21% |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | -3.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.21% |
| Jun 30, 2026 | 56.21% |
| Jun 30, 2026 | 56.21% |
| Mar 31, 2026 | -14.23% |
| Mar 31, 2026 | -14.23% |
| Mar 31, 2026 | -14.23% |
| Dec 31, 2025 | -27.83% |
| Dec 31, 2025 | -27.83% |
| Dec 31, 2025 | -27.83% |
| Sep 30, 2025 | -12.70% |
| Sep 30, 2025 | -12.70% |
| Sep 30, 2025 | -12.70% |
| Jun 30, 2025 | -12.77% |
| Jun 30, 2025 | -12.77% |
| Jun 30, 2025 | -12.77% |
| Mar 31, 2025 | -15.94% |
| Mar 31, 2025 | -15.94% |
| Mar 31, 2025 | -15.94% |
| Dec 31, 2024 | -18.46% |
| Dec 31, 2024 | -18.46% |